Milner welcomes paediatric patients for Patient Research & Science day
The Milner team enjoyed an institute visit with a difference last week, as we welcomed a group of children for Inflammatory Bowel Disease (IBD) Patient Day. The day — organised by Milner collaborator Dr Matthias Zilbauer and the Wellcome MRC Cambridge Stem Cell...
Milner Institute celebrates success of first hybrid Therapeutics Symposium
Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert Hall, with a further 200+ delegates opting to view the talks via the online symposium platform! A selection of photographs...
AI drug target discovery company co-founded by Namshik Han receives £1.4 million pre-seed investment
CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI). CardiaTec is developing a target discovery platform for analysing...
Deputy Director Kathryn Chapman receives CEO Today Business Women of the Year Award
The CEO Today Business Women of the Year Awards 2022 edition has been published this week, and we’re delighted that Milner Deputy Director Kathryn Chapman has been announced as an awardee. Dedicated to recognising the achievements of today’s female leaders and...